- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07938255
Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity
Development and Application of Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity Among Older Adults
This clinical study aims to develop and apply early-warning and precision-intervention technologies for older adults with declining intrinsic capacity. It intends to identify key digital biomarkers, build dynamic prediction models, and verify the effectiveness of a human-computer interactive adaptive closed-loop intervention system, so as to shift geriatric health management from reactive medical care to proactive health management. The main questions it aims to answer are:
Can multi-modal digital data enable early warning of intrinsic capacity decline among community-dwelling older adults?
Does the AI-driven personalized stepped intervention reduce the incidence of intrinsic capacity decline and adverse health events in older adults?Researchers will compare an integrated whole-course intrinsic-capacity management platform intervention versus routine community-based geriatric health services through a cluster-randomized controlled trial.Participants will:
Complete baseline multi-modal assessments including standard scales and wearable-device-based physiological monitoring Receive follow-up assessments every 3-6 months for 12-24 months in the cohort phase Be assigned to either the intervention group or the control group for a 6-month intervention period Undergo multi-dimensional evaluations at baseline, month 3, month 6 and month 12 Comply with health-management requirements or routine community health services according to group assignment
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Huafang Zhang
- Numéro de téléphone: 86-579-89935056
- E-mail: wuyizhangyichi@zju.edu.cn
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Aged 60 years or older
- Residing stably in the affiliated community for at least 6 months
- Conscious and able to cooperate with assessments and device operation (individuals at risk of mild cognitive impairment may participate with assistance)
- Voluntary participation with written informed consent signed
Exclusion Criteria:
- Severe cognitive impairment or acute phase of psychiatric illness, unable to cooperate with assessment or intervention
- Severe heart, lung, liver, or kidney failure, or terminal stage of malignant tumor
- Skin damage, infection, or other conditions affecting wearing of wearable devices
- Judged by the investigator to be unsuitable for participation in the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention
Participants receive the Intrinsic Capacity (IC) whole-course management platform intervention for 6 months, with follow-up to 12 months. The intervention includes: (1) an LLM-driven multi-agent AI health coach (knowledge-delivery, empathetic communication, and quality supervision agents); (2) continuous wearable device monitoring (blood pressure, heart rate, activity pattern, sleep architecture, skin temperature, dual-task gait); and (3) risk-stratified, individualized stepped prescriptions covering five domains: nutrition, exercise, cognition, psychological health, and sensory function. The platform collects adherence data in real time and dynamically adjusts the intervention plan (Just-In-Time Adaptive Intervention, JITAI). |
A multi-agent, LLM-driven AI health coach system (knowledge-delivery, empathetic communication, and quality supervision agents) combined with a Just-In-Time Adaptive Intervention (JITAI) decision engine, delivering risk-stratified, individualized stepped interventions across five domains: nutrition, exercise, cognition, psychological health, and sensory function. Delivered for 6 months via the IC whole-course management platform. Wearable devices continuously monitor dynamic blood pressure, heart rate, activity patterns, sleep architecture, skin temperature, and dual-task gait. Device data are uploaded in real time to the platform and used to trigger adaptive, individualized intervention recommendations. |
|
Aucune intervention: Control
Participants receive routine community health management services for older adults as usually provided by the community health service center, including regular physical examination and standard health education. Intervention duration is 6 months, with follow-up to 12 months. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of Intrinsic Capacity Decline
Délai: From baseline to 12 months
|
The proportion of participants who experience a clinically significant decline in at least one of the five WHO intrinsic capacity domains during follow-up. Each domain is assessed at baseline and at 3, 6, and 12 months using a single prespecified instrument: cognition (MoCA), locomotion (SPPB), psychological status (GDS-15), vitality (MNA-SF), and sensory function (vision and hearing tests). Each instrument is converted against a prespecified threshold into a binary decline judgement (yes/no). These five binary judgements are aggregated into one composite endpoint: a participant is counted as having an event if decline is present in any domain. Only one value is reported, the percentage of participants meeting this composite definition at 12 months, expressed as a percentage of participants. |
From baseline to 12 months
|
|
Incidence of Adverse Health Events
Délai: From baseline to 12 months
|
The proportion of participants experiencing at least one event of a composite of adverse health events (falls, emergency department visits, hospitalizations, or death) during follow-up. Each event type is recorded as a binary occurrence and verified against medical records at the 3-, 6-, and 12-month assessments. The four event types are aggregated into a single composite binary endpoint: each participant is counted once if any component event occurs. Only one value is reported, the percentage of participants with at least one component event at 12 months, expressed as a percentage of participants. |
From baseline to 12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Cognitive Function (MoCA Score)
Délai: Baseline to 12 months
|
Change from baseline in the Montreal Cognitive Assessment (MoCA) score at 3, 6, and 12 months. Reported as change in MoCA score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Locomotion (SPPB Score)
Délai: Baseline to 12 months
|
Change from baseline in the Short Physical Performance Battery (SPPB) score at 3, 6, and 12 months. Reported as change in SPPB score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Psychological Status (GDS-15 Score)
Délai: Baseline to 12 months
|
Change from baseline in the 15-item Geriatric Depression Scale (GDS-15) score at 3, 6, and 12 months. Reported as change in GDS-15 score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Vitality / Nutritional Status (MNA-SF Score)
Délai: Baseline to 12 months
|
Change from baseline in the Mini Nutritional Assessment Short-Form (MNA-SF) score at 3, 6, and 12 months. Reported as change in MNA-SF score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Sensory Function Score
Délai: Baseline to 12 months
|
Vision and hearing test results are converted according to a prespecified grading rule into a single sensory domain score ranging from 0 to 100. Change from baseline in this sensory domain score is assessed at 3, 6, and 12 months. Reported as change in score points; only one value is reported. |
Baseline to 12 months
|
|
Change in Intrinsic Capacity Digital Index
Délai: Baseline to 12 months
|
Change from baseline in the composite Intrinsic Capacity Digital Index (0-10), derived by aggregating multimodal wearable and assessment data at 3, 6, and 12 months. Reported as change in index score points; only one value is reported. |
Baseline to 12 months
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- KY-2026-0221
- No.2026C02A1144 (Autre identifiant: Key R&D Program of Zhejiang)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .